Zacks27d agoneutral
Here's Why You Should Add Merit Medical Stock to Your Portfolio NowMMSI's portfolio, acquisitions, R&D strategy and WRAPSODY upside support growth, though tariffs, China pressure and OEM headwinds persist.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
530last 24h
2505last 7d
477● bullish (7d)
254● bearish (7d)
197publishers
Zacks43d agoneutral
Reasons to Hold AngioDynamics Stock in Your Portfolio for NowANGO's NanoKnife growth, strong Med Tech momentum and solid Q3 results support holding the stock despite tariff and inflation pressures.
Zacks58d agoneutral
Here's Why You Should Retain Merit Medical Stock in Your Portfolio NowMMSI leans on therapeutic strength, an oncology acquisition and a new stent launch, but tariffs, OEM weakness and China pressure shadow 2026.
Zacks76d agoneutral
Reasons to Add West Pharmaceutical Stock to Your Portfolio NowWST's HVP business and GLP-1 demand are driving growth, but can Annex 1 tailwinds and margin gains offset inflation and SmartDose risks?